Pharsight

Provigil generic

Provigil is an alertness-promoting drug owned by Cephalon. It became available in the market on December 24, 1998. The active ingredient in Provigil is modafinil. It is available in a tablet;oral dosage form.

When will Provigil generic be available?

One of the patents of Provigil has already expired. The remaining patent, US7297346*PED on 'Pharmaceutical formulations of modafinil', is set to expire on May 29, 2024. This determines when the generics of Provigil can be released. So, we can expect Provigil generic to be available after May 29, 2024.

Provigil uses

Provigil is used to treat excessive sleepiness caused by narcolepsy or shift work sleep disorder. modafinil, the active ingredient in Provigil, works by changing the amounts of certain natural substances in the area of the brain that controls sleep and wakefulness.

Provigil patent expiration

Provigil has a total of two drug patents, one of which has already expired. The remaining patent which influences the release of the Provigil generic is patent US7297346*PED entitled 'Pharmaceutical formulations of modafinil'. This patent will expire on May 29, 2024. Below is the detail of the patent:

Provigil dosage

Want to ask something?